n the world of microbiology, a small yet mighty microbe has been causing quite a stir since its discovery in 2004. Meet Akkermansia, one of the most promising probiotics that has earned the title of "next-generation beneficial microbes" for its potential health benefits and therapeutic applications.

Akkermansia is a type of bacteria that resides in the human gastrointestinal tract, specifically in the mucus layer lining the intestines. It belongs to the Verrucomicrobia phylum and is a Gram-negative, anaerobic microorganism. This bacterium was first discovered in 2004 and has since garnered significant attention due to its potential health benefits.